Health Oct 08 How GLP-1s are reshaping cultural views on body image By Stephanie Sy, Mike Fritz, Sam Lane
Health Oct 07 Watch 10:36 The evidence suggesting GLP-1s can curb drug and alcohol cravings A growing body of evidence suggests that GLP-1 drugs are not only helping millions with their diabetes and weight loss, but they’re also proving effective at curbing people’s desire for drugs and alcohol. William Brangham reports on the researchers who… By William Brangham, Mike Fritz
Health Oct 06 Watch 8:48 High cost of GLP-1s drives some to seek cheaper, unregulated versions Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping… By Stephanie Sy, Sam Lane, Mike Fritz
Health Oct 05 Watch 6:54 As GLP-1s reshape America, questions and new uses emerge Hailed by some as miracle drugs, GLP-1s have surged in popularity in the past few years. An estimated one out of every eight Americans is now on some version of them and scientists continue to research new potential uses. But… By William Brangham, Sam Lane, Mike Fritz
Health Jul 09 Watch 7:13 Some Medicare beneficiaries eligible for weight loss drug discounts The number of Americans taking a GLP-1 drug for weight loss is on the rise. A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago when just 3%… By William Brangham, Andrew Merlis, Solveig Rennan
Jun 19 Watch 7:40 Research shows weight-loss drugs may also reduce cancer risk By William Brangham, Jackson Hudgins A growing body of research suggests popular weight-loss drugs like Ozempic and Wegovy may also help treat or prevent certain cancers. It’s the latest unexpected benefit to be associated with GLP-1s, which are now taken by one-in-eight American adults. William… Continue watching
Apr 01 FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity By JoNel Aleccia, Associated Press The Food and Drug Administration's decision Wednesday means patients in the United States will soon have access to a second daily oral medication to treat obesity and weight-related issues. Continue reading
Mar 14 What are peptides, and are they safe? Here's what to know By Grace Abels, PolitiFact Lots of people are talking about peptides. But what are they? Here’s a quick primer on the health trend and what we know about peptides’ safety. Continue reading
Mar 09 Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration By Michelle Chapman, Associated Press The companies on Monday announced a partnership in which Hims & Hers will sell Novo Nordisk's medications at "self-pay prices."… Continue reading
Nov 06 WATCH: Trump announces deal to expand coverage, lower costs on obesity drugs By Tom Murphy, Aamer Madhani, JoNel Aleccia, Associated Press President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy. Continue reading